ATM and breast carcinoma: Yet, not all studies confirmed the associated breast cancer risk conferred by being an ATM heterozygous mutation carrier (Vorechovsky et al, 1996; FitzGerald et al, 1997; Bay et al, 1998; Chen et al, 1998).